Sánchez-Ortega, Isabel <br/><br/>
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.  [electronic resource] 

 -  Croatian medical journal  Jun 2016 
 - 247-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1332-8166 
<br/><br/><label>Standard No.: </label>10.3325/cmj.2016.57.247  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Dasatinib--administration & dosage<br/>Female<br/>Graft vs Host Disease<br/>Humans<br/>Imatinib Mesylate--administration & dosage<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--therapy<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Salvage Therapy<br/>Sclerosis--complications<br/>Treatment Outcome